Cybin rebrands as Helus Pharma, keeps HELP ticker on Nasdaq and Cboe Canada

HELP•2026-10-01

Cybin changed its legal name to Helus Pharma and will continue trading on Nasdaq Global Market and Cboe Canada under ticker HELP. Its pipeline includes HLP003 in Phase 3 for major depressive disorder and HLP004 in Phase 2 for generalized anxiety disorder.

1. Name and pipeline

Cybin changed its legal name to Helus Pharma, rebranding around its serotonergic agonist drug-development platform. Shares will continue trading on Nasdaq Global Market and Cboe Canada under ticker HELP. Its pipeline includes HLP003 in Phase 3 for major depressive disorder and HLP004 in Phase 2 for generalized anxiety disorder.

Cybin rebrands as Helus Pharma, keeps HELP ticker on Nasdaq and Cboe Canada

1. Name and pipeline

Related News

Century Complete starts sales of Hudson Village homes in Cowpens, South Carolina from $231,888

BlackRock clumsily reverse-engineers retirement

Deep Isolation wins Texas drilling permit for nuclear waste disposal pilot in Cameron

Linkhome launches GPU Marketplace 2.0 to expand on-demand AI compute access

Taysha Gene Therapies highlights Phase 1/2 REVEAL trial data for TSHA-102 in Rett syndrome